Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study Protocol

Abstract Background Herpes zoster (HZ), triggered by the reactivation of the varicella-zoster virus, manifests as a painful rash known as zoster-associated pain (ZAP), which can progress to postherpetic neuralgia (PHN). This study evaluates the efficacy and safety of ultrasound-guided thoracic parav...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu Wang, Xinyu Lei, Zhixuan Lan, Ruilin He, Zongbin Jiang
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-12-01
Series:Pain and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40122-024-00691-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586065563615232
author Liu Wang
Xinyu Lei
Zhixuan Lan
Ruilin He
Zongbin Jiang
author_facet Liu Wang
Xinyu Lei
Zhixuan Lan
Ruilin He
Zongbin Jiang
author_sort Liu Wang
collection DOAJ
description Abstract Background Herpes zoster (HZ), triggered by the reactivation of the varicella-zoster virus, manifests as a painful rash known as zoster-associated pain (ZAP), which can progress to postherpetic neuralgia (PHN). This study evaluates the efficacy and safety of ultrasound-guided thoracic paravertebral injections of platelet-rich plasma (PRP) in managing acute ZAP and preventing PHN. Methods This is a prospective, randomized, controlled, open-label, endpoint-blinded, single-center trial involving 128 participants suffering from zoster-associated pain. Participants will be randomly assigned to the PRP treatment in combination with antiviral therapy group or the antiviral therapy group at a 1:1 ratio. Pain intensity (NRS-11), quality of life (SF-12), sleep quality (PSQI), pain characteristics, skin lesion recovery, average weekly consumption of rescue analgesics, and adverse events will be assessed. Follow-up assessments will be conducted at 1, 3, 6, and 12 months post-intervention to evaluate the incidence rate of PHN, pain intensity, quality of life, sleep quality, and safety. Ethics and Dissemination Adhering to the 2013 SPIRIT statement and the Declaration of Helsinki, this study has received ethical approval from the relevant committee. Results will be disseminated through scientific journals and conferences, contributing to global data on managing ZAP. Conclusions By comparing PRP with antiviral therapy, this trial seeks to establish a more effective treatment paradigm for reducing acute zoster-associated pain and the incidence of PHN, potentially setting a new standard in therapeutic strategies for HZ. Trial Registration This clinical trial is registered with the Chinese Clinical Trial Registry (ChiCTR) at https://www.chictr.org.cn/index.html (Registration Number: ChiCTR2400087248, Registration Date: 2024–07-23).
format Article
id doaj-art-782a2869992445108f5452836cb2bc1c
institution Kabale University
issn 2193-8237
2193-651X
language English
publishDate 2024-12-01
publisher Adis, Springer Healthcare
record_format Article
series Pain and Therapy
spelling doaj-art-782a2869992445108f5452836cb2bc1c2025-01-26T12:13:50ZengAdis, Springer HealthcarePain and Therapy2193-82372193-651X2024-12-0114142543610.1007/s40122-024-00691-6Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study ProtocolLiu Wang0Xinyu Lei1Zhixuan Lan2Ruilin He3Zongbin Jiang4Department of Pain Medicine, The Second Affiliated Hospital of Guangxi Medical UniversityDepartment of Pain Medicine, The Second Affiliated Hospital of Guangxi Medical UniversityDepartment of Pain Medicine, The Second Affiliated Hospital of Guangxi Medical UniversityDepartment of Pain Medicine, The Second Affiliated Hospital of Guangxi Medical UniversityDepartment of Pain Medicine, The Second Affiliated Hospital of Guangxi Medical UniversityAbstract Background Herpes zoster (HZ), triggered by the reactivation of the varicella-zoster virus, manifests as a painful rash known as zoster-associated pain (ZAP), which can progress to postherpetic neuralgia (PHN). This study evaluates the efficacy and safety of ultrasound-guided thoracic paravertebral injections of platelet-rich plasma (PRP) in managing acute ZAP and preventing PHN. Methods This is a prospective, randomized, controlled, open-label, endpoint-blinded, single-center trial involving 128 participants suffering from zoster-associated pain. Participants will be randomly assigned to the PRP treatment in combination with antiviral therapy group or the antiviral therapy group at a 1:1 ratio. Pain intensity (NRS-11), quality of life (SF-12), sleep quality (PSQI), pain characteristics, skin lesion recovery, average weekly consumption of rescue analgesics, and adverse events will be assessed. Follow-up assessments will be conducted at 1, 3, 6, and 12 months post-intervention to evaluate the incidence rate of PHN, pain intensity, quality of life, sleep quality, and safety. Ethics and Dissemination Adhering to the 2013 SPIRIT statement and the Declaration of Helsinki, this study has received ethical approval from the relevant committee. Results will be disseminated through scientific journals and conferences, contributing to global data on managing ZAP. Conclusions By comparing PRP with antiviral therapy, this trial seeks to establish a more effective treatment paradigm for reducing acute zoster-associated pain and the incidence of PHN, potentially setting a new standard in therapeutic strategies for HZ. Trial Registration This clinical trial is registered with the Chinese Clinical Trial Registry (ChiCTR) at https://www.chictr.org.cn/index.html (Registration Number: ChiCTR2400087248, Registration Date: 2024–07-23).https://doi.org/10.1007/s40122-024-00691-6Herpes zoster-associated painUltrasound-guidedPlatelet-rich plasmaAntiviral therapy
spellingShingle Liu Wang
Xinyu Lei
Zhixuan Lan
Ruilin He
Zongbin Jiang
Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study Protocol
Pain and Therapy
Herpes zoster-associated pain
Ultrasound-guided
Platelet-rich plasma
Antiviral therapy
title Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study Protocol
title_full Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study Protocol
title_fullStr Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study Protocol
title_full_unstemmed Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study Protocol
title_short Ultrasound-Guided Thoracic Paravertebral Injection of Platelet-Rich Plasma for the Treatment of Thoracic Herpes Zoster-Related Pain: A Study Protocol
title_sort ultrasound guided thoracic paravertebral injection of platelet rich plasma for the treatment of thoracic herpes zoster related pain a study protocol
topic Herpes zoster-associated pain
Ultrasound-guided
Platelet-rich plasma
Antiviral therapy
url https://doi.org/10.1007/s40122-024-00691-6
work_keys_str_mv AT liuwang ultrasoundguidedthoracicparavertebralinjectionofplateletrichplasmaforthetreatmentofthoracicherpeszosterrelatedpainastudyprotocol
AT xinyulei ultrasoundguidedthoracicparavertebralinjectionofplateletrichplasmaforthetreatmentofthoracicherpeszosterrelatedpainastudyprotocol
AT zhixuanlan ultrasoundguidedthoracicparavertebralinjectionofplateletrichplasmaforthetreatmentofthoracicherpeszosterrelatedpainastudyprotocol
AT ruilinhe ultrasoundguidedthoracicparavertebralinjectionofplateletrichplasmaforthetreatmentofthoracicherpeszosterrelatedpainastudyprotocol
AT zongbinjiang ultrasoundguidedthoracicparavertebralinjectionofplateletrichplasmaforthetreatmentofthoracicherpeszosterrelatedpainastudyprotocol